Manipal Health Enterprises (NSE:MANIPALHOS) Revenue: ₹ Mil (TTM As of Mar. 2026)

Author: Vera Yuan Vera Yuan
Vera Yuan
Vera Yuan
Director of Data and Quant Analytics at GuruFocus
Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Reviewed by: Charlie Tian Charlie Tian
Charlie Tian
Charlie Tian
Founder & CEO of GuruFocus
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.

NSE:MANIPALHOS Manipal Health Enterprises Ltd NSE:MANIPALHOS
13 GF Score
Price ₹771.65
! 1 Warning Sign
View Full Analysis

What is Manipal Health Enterprises Revenue?

Manipal Health Enterprises NSE:MANIPALHOS -3.30% 13 Revenue is ₹ Mil as of Mar. 2026. GuruFocus rates NSE:MANIPALHOS with a GF Score™ of 13/100. The stock has 1 warning sign investors should review.

Manipal Health Enterprises's revenue for the six months ended in Mar. 2026 was ₹109,356 Mil. Manipal Health Enterprises does not have enough years/quarters to calculate its revenue for the trailing twelve months (TTM) ended in Mar. 2026. Manipal Health Enterprises's Revenue per Share for the six months ended in Mar. 2026 was ₹83.14. Manipal Health Enterprises does not have enough years/quarters to calculate its Revenue per Share for the trailing twelve months (TTM) ended in Mar. 2026.

During the past 12 months, the average Revenue per Share Growth Rate of Manipal Health Enterprises was 18.10% per year. Please click Growth Rate Calculation Example (GuruFocus) to see how GuruFocus calculates Wal-Mart Stores Inc (WMT)'s revenue growth rate. You can apply the same method to get other companies' revenue growth rate using Revenue per Share data.

Manipal Health Enterprises  (NSE:MANIPALHOS) Revenue Explanation

In ranking the predictability, companies with more consistent revenue and earnings growth are ranked high with predictability.

Peter Lynch categorized companies according to their revenue growth:


Slow Grower: Inflation < 10-Year Revenue Growth Rate < 10%:
Stalwart: 10% < 10-Year Revenue Growth Rate < 20%:
Fast Grower: 10-Year Revenue Growth Rate > 20%:

His favorite companies are stalwart, those growing between 10-20% a year.

Companies in cyclical industries may see their revenue fluctuate wildly in good years and bad years.

Be Aware

Revenue can be manipulated by changing the way how revenue is booked. Companies may book sales before the payment is received, or before the revenue is fully earned. These will be added to balance sheet items such as account payable or account receivables.

Manipal Health Enterprises Revenue Related Terms

Manipal Health Enterprises Revenue Historical Data

* Premium members only.

The historical data trend for Manipal Health Enterprises's Revenue can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Manipal Health Enterprises Revenue Chart

Manipal Health Enterprises Annual Data
Trend Mar24 Mar25 Mar26
Revenue
60,793.90 92,635.56 109,356.18

Manipal Health Enterprises Semi-Annual Data
Mar24 Mar25 Mar26
Revenue 60,793.90 92,635.56 109,356.18

NSE:MANIPALHOS vs : Revenue Comparison

For the Medical Care Facilities subindustry, Manipal Health Enterprises's Revenue, along with its competitors' market caps and Revenue data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.

Manipal Health Enterprises Revenue vs Healthcare Providers & Services Industry

For the Healthcare Providers & Services industry and Healthcare sector, Manipal Health Enterprises's Revenue distribution charts can be found below:

* The bar in red indicates where Manipal Health Enterprises's Revenue falls into.


NSE:MANIPALHOS
13GF Score
Manipal Health Enterprises Ltd NSE:MANIPALHOS
Revenue is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

Manipal Health Enterprises Revenue Calculation

Also referred as sales, revenue is income that a company receives from its normal business activities, usually from the sale of goods and services to customers. Revenue is often referred to as the "top line" due to its position on the income statement at the very top.

Frequently Asked Questions Learn more about Revenue →
What does a Revenue of ₹ Mil mean?
Manipal Health Enterprises (NSE:MANIPALHOS) has a Revenue of ₹ Mil as of Mar. 2026. Revenue is the total amount a company generates as sales through its operations. View historical data on Manipal Health Enterprises and its competitors.
Is Manipal Health Enterprises' Revenue too high?
Manipal Health Enterprises' current Revenue is ₹ Mil. Overall, Manipal Health Enterprises has a GF Score™ of 13/100, reflecting its overall financial health beyond just this single metric.
How does Manipal Health Enterprises' Revenue compare to ?
Manipal Health Enterprises' Revenue of ₹ Mil can be compared against companies in the Healthcare Providers & Services industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Revenue for a Healthcare Providers & Services company?
A good Revenue depends on the Healthcare Providers & Services industry context. However, Revenue should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Revenue mean?
A high Revenue can signal that a stock is expensive relative to its fundamentals. Revenue is the total amount a company generates as sales through its operations. View historical data on Manipal Health Enterprises and its competitors. Manipal Health Enterprises's current Revenue is ₹ Mil. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Manipal Health Enterprises stock overvalued right now?
Manipal Health Enterprises (NSE:MANIPALHOS) has a current Revenue of ₹ Mil. The current Revenue is ₹ Mil. Manipal Health Enterprises' overall GF Score™ is 13/100 with 1 warning sign to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Revenue calculated?
Revenue is calculated from a company's financial statements. For Manipal Health Enterprises (NSE:MANIPALHOS), the current Revenue is ₹ Mil as of Mar. 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Manipal Health Enterprises Business Description

Comparable Companies
Other Exchanges 544847:India
Address HAL Airport Road, Rustom Bagh road, The Annexe, no. 98/2, Bengaluru, KA, IND, 560 017
Manipal Health Enterprises Ltd is engaged in the business of running/managing hospitals and providing healthcare services. The company operates through various Hospitals/clinics providing Healthcare services and diagnostic centres in India. It offers clinical services across several specialties, with a focus on tertiary and quaternary care, particularly in cardiac sciences, oncology, neurosciences, gastro sciences, orthopedics, and renal sciences. It has a single business segment, namely engaged in the business of healthcare services. The company generates revenue by providing inpatient care at its hospitals.
13GF Score

Get the complete analysis for NSE:MANIPALHOS

Revenue is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

₹771.65
Price